Suppr超能文献

长期维生素 D 补充对 2 型糖尿病中老年患者代谢特征的影响。

Effects of long-term vitamin D supplementation on metabolic profile in middle-aged and elderly patients with type 2 diabetes.

机构信息

School of Public Health and Management, Binzhou Medical University, 346 Guanhai Road, Yantai 264003, China; Department of Occupational and Environmental Health, School of Public Health, Medical College of Soochow University, 199 Renai Road, Suzhou 215123, China.

Department of Occupational and Environmental Health, School of Public Health, Medical College of Soochow University, 199 Renai Road, Suzhou 215123, China; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, School of Public Health, Medical College of Soochow University, 199 Renai Road, Suzhou 215123, China.

出版信息

J Steroid Biochem Mol Biol. 2023 Jan;225:106198. doi: 10.1016/j.jsbmb.2022.106198. Epub 2022 Sep 29.

Abstract

To evaluate the effects of long-term vitamin D supplementation on metabolic profiles in middle-aged to elderly patients with type 2 diabetes (T2D), a randomized controlled trial was conducted among patients with T2D aged 50-70 years. A total of 270 patients underwent randomization with 135 being allocated to the vitamin D group and 135 to the control group, and participants in the vitamin D group received oral vitamin D (800 IU/day) for 30 months. Serum 25(OH)D and metabolic variables were measured at baseline, and after 6, 12, 18, and 30 months of intervention. After 30 months, the vitamin D group showed a greater increase in serum 25(OH)D than the control group (12.39 ± 6.99 vs 5.35 ± 5.29 ng/ml, P < 0.001). Meanwhile, changes in the levels of fasting insulin, HOMA-IR, non-high-density-lipoprotein cholesterol (non-HDL-C), high-sensitivity C-reactive protein (hs-CRP), and uric acid differed significantly between the two groups (all P < 0.05). Stratified analysis indicated that change in uric acid differed significantly between the two groups in subgroup with baseline 25(OH)D ≥ 20 ng/ml (P = 0.042) or subgroup with female patients (P = 0.034). And the change in fasting blood glucose (FBG) differed significantly between the vitamin D group (-0.30 ± 2.52 mmol/L) and the control group (0.49 ± 1.78 mmol/L, P = 0.049) among patients achieving 25(OH)D concentrations of 30 ng/ml at the end of this trial. A significant difference in the change of triglyceride was observed between the two groups among patients with obesity at baseline [0.05(-0.59, 0.23) vs 0.41(-0.01, 0.80) mmol/L, P = 0.023]. These findings suggested that long-term vitamin D supplementation significantly reduced fasting insulin, HOMA-IR, and serum concentrations of non-HDL-C, hs-CRP, and uric acid among middle-aged to elderly patients with T2D. And vitamin D status, gender, and baseline obesity may modify the effects of vitamin D supplementation.

摘要

为了评估长期维生素 D 补充对 50-70 岁 2 型糖尿病(T2D)中老年患者代谢谱的影响,对 270 例 T2D 患者进行了一项随机对照试验,患者被随机分配至维生素 D 组(n=135)和对照组(n=135),维生素 D 组接受口服维生素 D(800IU/天)治疗 30 个月。分别在基线、干预后 6、12、18 和 30 个月测量血清 25(OH)D 和代谢变量。30 个月后,与对照组相比,维生素 D 组血清 25(OH)D 升高更明显(12.39±6.99 vs 5.35±5.29ng/ml,P<0.001)。同时,两组空腹胰岛素、HOMA-IR、非高密度脂蛋白胆固醇(non-HDL-C)、高敏 C 反应蛋白(hs-CRP)和尿酸水平的变化也有显著差异(均 P<0.05)。分层分析表明,在基线 25(OH)D≥20ng/ml 亚组(P=0.042)或女性亚组(P=0.034)中,两组尿酸变化差异有统计学意义。维生素 D 组(-0.30±2.52mmol/L)和对照组(0.49±1.78mmol/L,P=0.049)的空腹血糖(FBG)变化在本试验结束时 25(OH)D 浓度达到 30ng/ml 的患者中差异有统计学意义。在基线肥胖患者中,两组间甘油三酯的变化也有显著差异[0.05(-0.59,0.23)vs 0.41(-0.01,0.80)mmol/L,P=0.023]。这些结果表明,长期维生素 D 补充可显著降低中老年 T2D 患者空腹胰岛素、HOMA-IR 及非高密度脂蛋白胆固醇、hs-CRP 和尿酸水平。维生素 D 状态、性别和基线肥胖可能会影响维生素 D 补充的效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验